NOVAVAX INC (NVAX)
Biological Products, (No Diagnostic Substances) · Healthcare · $1.5B
Intrinsic Value (Consensus)
$36.38
Current Price
$9.20
Margin of Safety
+295.4%
295.4% Below Intrinsic Value
Value: $36
Price: $9
Valuation Model Estimates
Current Price: $9.20
DCF (Discounted Cash Flow)
$32.48
Graham Number
Not applicable
—
Earnings Power Value
$25.05
Relative Value (P/E)
$51.60
Dividend Discount Model
Not applicable
—
Consensus Value
$36.38
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
55
Profitability
10/25
Strength
7/25
Valuation
22/25
Growth
16/25
Financial Health Signals
Negative free cash flow — company is burning cash
Key Financials
- EPS (TTM)
- $2.58
- EPS (Forward)
- $2.71
- Book Value
- $-0.78
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 64.7%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance